| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kumar Dinesh M. | Chief Medical Officer | C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA | /s/ Kathy Diep, as Attorney-in-Fact | 09 Mar 2026 | 0001850439 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASTH | Common Stock | Tax liability | -1,697 | -0.84% | $25.07* | 200,335 | 05 Mar 2026 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026. |
| F2 | Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. |
| F3 | Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan. |